Advanced Search
Latest accepted have been peer-reviewed and accepted, which are not yet assigned to volumes /issues, but are citable by Digital Object Identifier (DOI).
Articles in press have been peer-reviewed and accepted, which are not yet assigned to volumes /issues, but are citable by Digital Object Identifier (DOI).
Assistance of artificial intelligence in new drug development
JIANG Zhengyu, YOU Qidong
2024, 55(3): 281-283. DOI: 10.11665/j.issn.1000-5048.2024060302
Abstract FullText HTML PDF
Reflections on improving drug success rates with AIDD and CADD
CHEN Baiyu, LYU Lunan, XU Xiaodi, ZHANG Ying, LI Wei, FU Wei
2024, 55(3): 284-294. DOI: 10.11665/j.issn.1000-5048.2024011302
Abstract FullText HTML PDF
Research progress of artificial intelligence-based small molecule generation models in drug discovery
TANG qian, CHEN Roufen, SHEN Zheyuan, CHI Xinglong, CHE Jinxin, DONG Xiaowu
2024, 55(3): 295-305. DOI: 10.11665/j.issn.1000-5048.2024031501
Abstract FullText HTML PDF
Research on machine learning-based activity prediction models for KRAS inhibitors
DU Ke, RONG Danqi, LU Rui, ZHANG Xiaoya, ZHAO Hongping
2024, 55(3): 306-315. DOI: 10.11665/j.issn.1000-5048.2024031102
Abstract FullText HTML PDF
Advances in the application of machine learning in the identification and authentication of synthetic cannabinoids
XU Qing, LYU Min, DENG Hongxiao, HU Chi, XIANG Ping, CHEN Hang
2024, 55(3): 316-325. DOI: 10.11665/j.issn.1000-5048.2023113003
Abstract FullText HTML PDF
Optimization of Menin inhibitors based on artificial intelligence-driven molecular factory technology
ZENG Hao, WU Guozhen, ZOU Wuxin, WANG Zhe, SONG Jianfei, SHI Hui, WANG Xiaojian, HOU Tingjun, DENG Yafeng
2024, 55(3): 326-334. DOI: 10.11665/j.issn.1000-5048.2024040904
Abstract FullText HTML PDF
Advances in the application of artificial intelligence in nucleic acid drug development
HU Zi’ang, GAO Liming, YU Wenying
2024, 55(3): 335-346. DOI: 10.11665/j.issn.1000-5048.2024033101
Abstract FullText HTML PDF
Applications and challenges of artificial intelligence in the development of anticancer peptides
ZHANG Zhixing, DENG Hua, TANG Yun
2024, 55(3): 347-356. DOI: 10.11665/j.issn.1000-5048.2024040201
Abstract FullText HTML PDF
Design, synthesis and structure-activity relationship of a series of novel BCR-ABL inhibitors
WANG Yongjian, GUO Ming
2024, 55(3): 357-366. DOI: 10.11665/j.issn.1000-5048.2023042302
Abstract FullText HTML PDF
Design, synthesis and antiplatelet aggregation activity of 3-acetyl-7-hydroxycoumarin derivatives
SHANG Feiyang, LIU Chengbo, TAN Hongzhou, HE Bing, HE Liqin
2024, 55(3): 367-374. DOI: 10.11665/j.issn.1000-5048.2023072901
Abstract FullText HTML PDF
Design, synthesis and biological activity evaluation of water-soluble borneol phosphate prodrug
ZHANG Lulu, SUN Meiling, QIN Yajuan, LI Tingyou
2024, 55(3): 375-380. DOI: 10.11665/j.issn.1000-5048.2023060703
Abstract FullText HTML PDF
Preparation of high-drug-loading cantharidin polymer micelle delivery system and its anti-breast cancer activity
LIU Silu, BAI Yun, WANG Jianhua, ZHANG Keqing, SUN Yanxue, ZHANG Kexin, XU Pengcheng
2024, 55(3): 381-389. DOI: 10.11665/j.issn.1000-5048.2023102501
Abstract FullText HTML PDF
Reward effect of flubromazolam and its underlying neural circuit mechanism
HUANG Weiguo, JIANG Weikai, SHAO Yuwei, CHEN Zhigang, TANG Susu, HONG Hao
2024, 55(3): 390-396. DOI: 10.11665/j.issn.1000-5048.2024030401
Abstract FullText HTML PDF
Screening of adjuvant for PD-L1 vaccine based on nitrated T cell epitope
ZHOU Hongyou, GAO Xiangdong, YAO Wenbing, TIAN Hong
2024, 55(3): 397-403. DOI: 10.11665/j.issn.1000-5048.2023032801
Abstract FullText HTML PDF
Generation and characterization of humanized monoclonal antibody against human IFNAR1
QIU Jiwan, KONG Yong, CHEN Wei, XU Lei, CAO Chunjie, CHEN Tao, WU Yiliang
2024, 55(3): 404-411. DOI: 10.11665/j.issn.1000-5048.2024031401
Abstract FullText HTML PDF
Research progress on the function of ectopic olfactory receptors and their value as drug targets
LIU Chang, ZHAO Yongxin, GE Beibei, WEI Bin, GAO Yong
2024, 55(3): 412-419. DOI: 10.11665/j.issn.1000-5048.2023092001
Abstract FullText HTML PDF
Research progress in STAT3/Th17 cells and Sjögren syndrome
WANG Jiang, ZHAO Xueyan, FANG Weirong
2024, 55(3): 420-428. DOI: 10.11665/j.issn.1000-5048.2023041805
Abstract FullText HTML PDF

Special Issues

More+

Total visits：